Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/18/2012US8333961 Natural liniment for treatment of skin cancers
12/18/2012US8333960 Treatment of degenerated disc with autologous cells
12/18/2012US8333958 HSA-free formulations of interferon-Beta
12/18/2012US8333953 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/18/2012US8333193 Dry powder inhalation system for transpulmonary administration
12/18/2012CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/18/2012CA2519873C Fvii or fviia variants
12/18/2012CA2508219C Ace inhibitory peptides from plant materials
12/18/2012CA2489275C Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests for diagnosis and management of aisnhl
12/18/2012CA2472163C Psoriasin expression by breast epithelial cells
12/18/2012CA2466034C Stable aqueous pharmaceutical formulations of daclizumab antibodies
12/18/2012CA2460468C Novel polypeptide, dna thereof and use of the same
12/18/2012CA2407895C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
12/18/2012CA2398064C 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
12/18/2012CA2392545C Pharmaceutical formulations for thyroid hormones
12/18/2012CA2385122C Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
12/18/2012CA2375269C A method of prophylaxis and treatment and agents useful for same
12/18/2012CA2363486C Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol
12/18/2012CA2345109C Receptor based antagonists and methods of making and using
12/18/2012CA2327382C Neovascularization inhibitors
12/18/2012CA2292902C Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases
12/15/2012CA2766417A1 Stabilized therapeutic small helical antiviral peptides
12/13/2012WO2012171031A1 Treatment of coagulation disease by administration of recombinant vwf
12/13/2012WO2012170979A1 Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof
12/13/2012WO2012170969A2 Pro-coagulant compounds and methods of use thereof
12/13/2012WO2012170957A2 Retinoid-liposomes for enhancing modulation of hsp47 expression
12/13/2012WO2012170955A1 Therapeutic agents for regulating serum phosphorus
12/13/2012WO2012170938A1 Compositions and methods for increasing serum half-life
12/13/2012WO2012170930A1 Lipid nanoparticle compositions and methods for mrna delivery
12/13/2012WO2012170918A2 Methods of treatment for retinal diseases
12/13/2012WO2012170899A2 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases
12/13/2012WO2012170804A1 Treatments for gastrointestinal disorders
12/13/2012WO2012170776A2 Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy
12/13/2012WO2012170766A1 Treatments for gastrointestinal disorders
12/13/2012WO2012170617A1 Pseudomonas exotoxin a with less immunogenic t cell and/or b cell epitopes
12/13/2012WO2012170524A1 Use of modified vasoactive intestinal peptides in the treatment of hypertension
12/13/2012WO2012170513A2 He4 based therapy for malignant disease
12/13/2012WO2012170495A1 Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
12/13/2012WO2012170452A2 Compositions and methods for treating neurodegenerative diseases
12/13/2012WO2012170392A2 Shk-based pharmaceutical compositions and methods of manufacturing and using the same
12/13/2012WO2012170289A1 Method of producing factor viii proteins by recombinant methods
12/13/2012WO2012170113A1 Scaffold-kinase interaction blockades and uses thereof in treating cancer
12/13/2012WO2012170072A1 Engineered antibody-tnfsf member ligand fusion molecules
12/13/2012WO2012169892A2 The use of alkaline phosphatase for preserving renal function
12/13/2012WO2012169822A2 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same
12/13/2012WO2012169798A2 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
12/13/2012WO2012169735A2 Complex comprising water-soluble fragments of fcεri and composition comprising same for treating allergic diseases mediated by ige
12/13/2012WO2012169579A1 Heterocyclic carboxylic acid ester derivative
12/13/2012WO2012169435A1 Freeze-dried preparation containing high-purity pth and method for producing same
12/13/2012WO2012169348A1 Novel application of reduced-fat soybean protein material to soybean-derived raw material-containing food or beverage
12/13/2012WO2012168944A1 Therapeutic compounds for immunomodulation
12/13/2012WO2012168908A1 Peptides for use in cancer treatment
12/13/2012WO2012168820A1 Polymyxin derivatives useful as antibacterial agents
12/13/2012WO2012168680A1 Pharmaceutical preparation comprising recombinant fsh
12/13/2012WO2012168486A1 Cetp fragments
12/13/2012WO2012168484A1 Targets and agents for the treatment of impaired bone fracture healing
12/13/2012WO2012168464A1 Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof
12/13/2012WO2012168401A1 Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis
12/13/2012WO2012168336A1 Beta - hairpin peptidomimetics as cxc4 antagonists
12/13/2012WO2012168050A1 Use of epsilon-poly-l-lysine for increasing the bioavailability of antimicrobial peptides in the human skin
12/13/2012WO2012167870A1 Treatment of cancers and metastases with suspensions of cilengitide in carrier
12/13/2012WO2012167744A1 Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
12/13/2012WO2012167617A1 β INHIBITING PROTEIN 1, FRAGMENTS THEREOF, AND USE THEREOF
12/13/2012WO2012167370A1 Methods of phosvitin extraction and phosphopeptide preparation from egg yolk
12/13/2012WO2012167309A1 Macromolecules
12/13/2012WO2012142142A3 Adiponectin receptor agonists and methods of use
12/13/2012WO2012138867A3 Long-acting peptide analogs
12/13/2012WO2012121529A3 Composition for nerve-cell or endothelial-cell regeneration comprising a ninjurin action suppressing agent
12/13/2012WO2012121485A3 Method for inducing in vivo migration of stem cell
12/13/2012WO2012118353A3 Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer
12/13/2012WO2012118323A3 Fusion protein comprising albumin and a retinol-binding protein
12/13/2012WO2012115439A3 Composition comprising expression or activity regulators of akap12 for treating central nerve system diseases
12/13/2012WO2012094653A3 Compositions and methods for macromolecular drug delivery
12/13/2012WO2012065059A3 Treatment of atherosclerosis with bmp-alk3 antagonists
12/13/2012WO2004070015A9 Nematode pan and zp receptor-like sequences
12/13/2012US20120317664 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
12/13/2012US20120316241 Remedy for cartilage-related diseases
12/13/2012US20120316226 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor
12/13/2012US20120316219 Modulation of apolipoprotein(a) expression
12/13/2012US20120316120 Fluorine containing compounds and methods of use thereof
12/13/2012US20120316119 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity
12/13/2012US20120316118 Oligopeptide improving differentiation of osteoblasts
12/13/2012US20120316117 Process to produce fibrillar proteins and method of treatment using fibrillar proteins
12/13/2012US20120316116 Treatment of coagulation disease by administration of recombinant vwf
12/13/2012US20120316115 Methods and compositions for inhibiting angiogenesis
12/13/2012US20120316114 Variants of C-type Natriuretic Peptide
12/13/2012US20120316113 Fgf based fibrin binding peptides
12/13/2012US20120316112 Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein
12/13/2012US20120316111 BMP-2 Upregulating Compounds For Healing Bone Tissue And Screening Methods For Selecting Such Compounds
12/13/2012US20120316110 Injectable Cross-Linked Polymeric Preparations and Uses Thereof
12/13/2012US20120316109 Polymer-conjugated glycosylated neublastin
12/13/2012US20120316108 Phospholipid depot
12/13/2012US20120316107 Fibrillation-resistant insulin and insulin analogues
12/13/2012US20120316106 Synergistic antibiotic combinations and derivatives
12/13/2012US20120316105 Polymyxin Derivates Useful As Antibacterial Agents
12/13/2012US20120316104 Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
12/13/2012US20120316103 Cyclic antimicrobial peptides
12/13/2012US20120316102 Antimicrobial peptides of the cecropin family and therapeutic uses thereof
12/13/2012US20120316101 Peptides for targeting apoptotic cells and uses thereof
12/13/2012US20120316100 Therapeutic Use of Peptide Inhibitors of NADPH Oxidase; Aerosolization as a Delivery Mechanism
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 3163